These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25672739)

  • 1. [Drug development for overcoming dementia in Japan].
    Nakamura H
    Rinsho Shinkeigaku; 2014; 54(12):1181-3. PubMed ID: 25672739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of dementia: overview].
    Furukawa K; Ishiki A; Tomita N; Arai H
    Rinsho Shinkeigaku; 2014; 54(12):1171-3. PubMed ID: 25672736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond amyloid: the future of therapeutics for Alzheimer's disease.
    Lane RF; Shineman DW; Steele JW; Lee LB; Fillit HM
    Adv Pharmacol; 2012; 64():213-71. PubMed ID: 22840749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status and perspectives on the development of AD therapeutics based on amyloid cascade hypothesis].
    Iwatsubo T
    Rinsho Shinkeigaku; 2013; 53(11):1039. PubMed ID: 24291872
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development of new drugs for Alzheimer's disease].
    Tabira T
    Brain Nerve; 2010 Jul; 62(7):787-96. PubMed ID: 20675883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down syndrome and Alzheimer's disease: Common pathways, common goals.
    Hartley D; Blumenthal T; Carrillo M; DiPaolo G; Esralew L; Gardiner K; Granholm AC; Iqbal K; Krams M; Lemere C; Lott I; Mobley W; Ness S; Nixon R; Potter H; Reeves R; Sabbagh M; Silverman W; Tycko B; Whitten M; Wisniewski T
    Alzheimers Dement; 2015 Jun; 11(6):700-9. PubMed ID: 25510383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: clinical trials and drug development.
    Mangialasche F; Solomon A; Winblad B; Mecocci P; Kivipelto M
    Lancet Neurol; 2010 Jul; 9(7):702-16. PubMed ID: 20610346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Alzheimer's disease drug development.
    Rafii MS; Aisen PS
    BMC Med; 2015 Mar; 13():62. PubMed ID: 25857341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data.
    Conrado DJ; Duvvuri S; Geerts H; Burton J; Biesdorf C; Ahamadi M; Macha S; Hather G; Francisco Morales J; Podichetty J; Nicholas T; Stephenson D; Trame M; Romero K; Corrigan B;
    Clin Pharmacol Ther; 2020 Apr; 107(4):796-805. PubMed ID: 31955409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers in Alzheimer's disease drug development.
    Cummings JL
    Alzheimers Dement; 2011 May; 7(3):e13-44. PubMed ID: 21550318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in biological psychiatry research on dementia: AD-FTLD spectrum].
    Takeda M
    Brain Nerve; 2012 Feb; 64(2):149-61. PubMed ID: 22308260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Novel Pharmaceutical Agents for Alzheimer's Disease: The Impact of Regulatory Initiatives in Japan and the United States.
    Tsukamoto K
    Clin Ther; 2015 Aug; 37(8):1652-60. PubMed ID: 25801940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of disease modifying drugs for dementia-focusing on anti-tau drugs-].
    Soeda Y; Takashima A
    Rinsho Shinkeigaku; 2014; 54(12):1178-80. PubMed ID: 25672738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerating Regulatory Science Initiatives for the Development of Drugs for Alzheimer's Disease in Japan.
    Moritoyo T
    Clin Ther; 2015 Aug; 37(8):1622-6. PubMed ID: 26342202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.
    Cacabelos R; Cacabelos P; Torrellas C; Tellado I; Carril JC
    Methods Mol Biol; 2014; 1175():323-556. PubMed ID: 25150875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug therapy for Alzheimer's disease].
    Shoji M
    Brain Nerve; 2010 Jul; 62(7):777-85. PubMed ID: 20675882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of disease modifying therapies in Alzheimer's disease: a regulatory viewpoint.
    Mani RB
    Stat Med; 2004 Jan; 23(2):305-14. PubMed ID: 14716731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of Alzheimer's disease using Chinese medicinal plants: from disease models to potential clinical applications.
    Su Y; Wang Q; Wang C; Chan K; Sun Y; Kuang H
    J Ethnopharmacol; 2014 Mar; 152(3):403-23. PubMed ID: 24412377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acetylcholinesterase inhibitors for treatment of Alzheimer's disease].
    Shinagawa S; Shigeta M
    Brain Nerve; 2014 May; 66(5):507-16. PubMed ID: 24807367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.